Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.
Authors
McEvoy, Sinead HNougaret, S
Abu-Rustum, N
Vargas, H
Sadowski, E
Menias, C
Shitano, F
Fujii, S
Sosa, R
Escalon, J
Sala, E
Lakhman, Y
Affiliation
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USAIssue Date
2017-05-20
Metadata
Show full item recordAbstract
Historically, cancer treatment has emphasized measures for the "cure" regardless of the long-term consequences. Advances in cancer detection and treatment have resulted in improved outcomes bringing to the fore various quality of life considerations including future fertility. For many young cancer patients, fertility preservation is now an integral component of clinical decision-making and treatment design. Optimal fertility-sparing options for young patients with gynecologic cancer are influenced by patient age, primary cancer, treatment regimens, and patient preferences. Possible approaches include embryo or oocyte cryopreservation, ovarian transposition, conservative surgery, and conservative medical treatment to delay radical surgery. These may be used alone or in combination to maximize fertility preservation. Awareness of the various fertility-sparing options, eligibility criteria, and the central role of magnetic resonance imaging in the proper selection of patients will enable radiologists to produce complete clinically relevant imaging reports and serve as effective consultants to referring clinicians. Knowledge of the potential imaging pitfalls is essential to avoid misinterpretation and guide appropriate management.Citation
Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management. 2017 Abdom RadiolJournal
Abdominal RadiologyDOI
10.1007/s00261-017-1179-3PubMed ID
28528388Type
ArticleLanguage
enISSN
2366-0058ae974a485f413a2113503eed53cd6c53
10.1007/s00261-017-1179-3
Scopus Count
Collections
Related articles
- Hematologic cancers in women: from fertility preservation to post-cancer fertility outcomes.
- Authors: Goldenberg E, Sonigo C, Rakrouki S, Vinolas C, Eustache F, Puy V, Willekens C, Lazarovici J, Sifer C, Becquart C, Mayeur A, Benoit A, Grynberg M, Peigné M
- Issue date: 2025 Jul 1
- Interventions for fertility preservation in women with cancer undergoing chemotherapy.
- Authors: Weterings MA, Glanville E, van Eekelen R, Farquhar C
- Issue date: 2025 Jun 19
- Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
- Authors: Danis RB, Pereira N, Elias RT
- Issue date: 2017 Nov 10
- ESHRE good practice recommendations on fertility preservation involving testicular tissue cryopreservation in children receiving gonadotoxic therapies†.
- Authors: ESHRE FP for Boys Working Group:, Mitchell RT, Eguizabal C, Goossens E, Grynberg M, Jahnukainen K, Le Clef N, Mulder CL, Neuhaus N, Rimmer MP, Stukenborg JB, van de Wetering MD, van Pelt AMM, Wyns C
- Issue date: 2025 Jun 27
- Techniques and endocrine-reproductive outcomes of ovarian transposition prior to pelvic radiotherapy in both gynecologic and non-gynecologic cancers: A systematic review and meta-analysis.
- Authors: Genovese F, Zambrotta E, Incognito GG, Gulino FA, Di Guardo F, Genovese D, Di Gregorio LM, Benvenuto D, Ciancio FF, Leanza V, Palumbo M
- Issue date: 2024 Jun